Filing Details

Accession Number:
0001104659-18-073869
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-19 20:04:23
Reporting Period:
2018-12-17
Accepted Time:
2018-12-19 20:04:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1621227 Adaptimmune Therapeutics Plc ADAP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1553053 M Lawrence Alleva 1480 Snow Berry Street
Park City UT 84098
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares With A Nominal Value Of Gbp0.001 Per Share Acquisiton 2018-12-17 47,280 $0.84 47,280 No 4 P Indirect Held by Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Held by Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares With A Nominal Value Of Gbp0.001 Per Share 70,584 Direct
Footnotes
  1. The ordinary shares whose purchase is reported on this line are represented by American Depositary Shares ("ADS") and are held in the form of ADSs by the Lawrence M. Alleva Revocable Trust. Each ADS represents six ordinary shares of Adaptimmune Therapeutics plc.
  2. The 47,280 ordinary shares reported in Column 4 and Column 5 are represented by 7,880 ADSs.
  3. The price reported in Column 4 of $0.84 per ordinary share is derived from the purchase price paid on December 17, 2018 of $5.006 per ADS divided by six.
  4. The 70,584 ordinary shares reported in Column 5 are represented by 11,764 ADSs. These shares are held in the form of ADSs by Mr. Alleva.